Incentives for pharmaceutical innovation: What’s working, what’s lacking

Margaret Kyle
Additional contact information
Margaret Kyle: CERNA i3 - Centre d'économie industrielle i3 - Mines Paris - PSL (École nationale supérieure des mines de Paris) - PSL - Université Paris Sciences et Lettres - I3 - Institut interdisciplinaire de l’innovation - CNRS - Centre National de la Recherche Scientifique

Post-Print from HAL

Date: 2022-09
References: Add references at CitEc
Citations:

Published in International Journal of Industrial Organization, 2022, 84, pp.102850. ⟨10.1016/j.ijindorg.2022.102850⟩

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:hal:journl:hal-03935839

DOI: 10.1016/j.ijindorg.2022.102850

Access Statistics for this paper

More papers in Post-Print from HAL
Bibliographic data for series maintained by CCSD ().